Search clinical trials for: M2 macrophages

Total 877 results

Regional Health Center in Kartuzy, Poland
Medical University of Gdansk

Completed

ProGrip Mesh Repair vs Lichtenstein Operation

Inguinal Hernia

Poland
Turku University Hospital

Suspended

The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI >30 (OPTICAP>30)

Intra-abdominal Infection | Acute Disease | Appendicitis | Gastrointestinal Disease | Other and Unspecified Acute Appendicitis

Finland
Wandercraft

Completed

Assessment of the Interest of the Atalante Device for Patients With Manual Wheelchairs (M1-M2)

Complete Motor Paraplegia

France
University of Massachusetts, Worcester
Genentech, Inc.; Millennium Pharmaceuticals, Inc.

Terminated

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

Lung Cancer

United States
Assiut University

Unknown

Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas

Cancer of Pancreas

Egypt
Institut Mutualiste Montsouris

Unknown

Prevention of Abdominal Incisional Hernia After Laparoscopic Digestive Surgery in Obese Patients (BMI>30kg/m2) (EVINOV)

Obesity

France
Second Affiliated Hospital, School of Medicine,...

Recruiting

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Ovarian Cancer

China
Fudan University

Unknown

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

Rectal Cancer

China
Meirav Kedmi MD
Johnson & Johnson

Unknown

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

Diffuse Large B Cell Lymphoma | Recurrent Disease | Refractory Cancer | Primary Mediastinal (Thymic) Large B-cell Lymphoma | Transformed Indolent Lymphoma

Israel
University of Turin, Italy

Recruiting

The BeLimumab Antiphospholipid Syndrome Trial (BLAST) (BLAST)

Antiphospholipid Syndrome

Italy
Samuel Lunenfeld Research Institute, Mount Sinai...

Completed

Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

Obesity | Postpartum Hemorrhage

Canada
Samuel Lunenfeld Research Institute, Mount Sinai...

Completed

Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

Postpartum Hemorrhage

Canada
Mohamed Gaber Allam
King Abdul Aziz Specialist Hospital

Completed

Effect of Arterio-venous ECMO on Severe Sepsis and ARDS

Patients With Respiratory Failure and Shocked

Saudi Arabia
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

Efficacy and Pharmacokinetics of Meropenem in Severe Septic Patients

Sepsis

China
Eli Lilly and Company

Completed

To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Japan
Pfizer

Completed

Irinotecan Study For Cervical Cancer

Uterine Cervical Neoplasms

Taiwan
AstraZeneca

Completed

Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2

Healthy Volunteers

United Kingdom
National Taiwan University Hospital

Unknown

The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma

Bladder Urothelial Carcinoma

Taiwan
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

The Impact of M1/M2 Tumor Associated Macrophage (TAM) Polarization on Cancer Progression and Prognosis Prediction

Lung Cancer | Tumor

Taiwan
Pfizer

Terminated

A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Alzheimer Disease

Australia, France, Finland, Portugal, Spain, United Kingdom, Poland, Japan, Italy, Belgium, Switzerland, Netherlands, Chile, Slovakia, Sweden, New Zealand, South Africa
University of Padova

Terminated

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Cirrhosis | Ascites | Nosocomial Spontaneous Bacterial Peritonitis

Italy
Callisto Pharmaceuticals

Unknown

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia

United States
Taipei Veterans General Hospital, Taiwan
National Taiwan University Hospital; China Medical University Hospital; Tri-Service... and other collaborators

Unknown

Genius Study Study to Compare Efficacy and Safety of Gefitinib/ Pemetrexed With Pemetrexed Alone as Maintenance Therapy in Patients With Stage IV EGFR Mutation Negative or T790M Single Mutation Who Respond to Pemetrexed/ Platinum as First-line Therapy

NSCLC

Taiwan
Nektar Therapeutics

Completed

NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)

Colorectal Cancer | Tumor

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Terminated

The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy

Cancer

United States
Seoul National University Hospital

Completed

PET in Breast Cancer Receiving Neoadjuvant Chemotherapy (DA-PET)

Breast Cancer
Aileron Therapeutics, Inc.

Terminated

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Prevention of Chemotherapy-induced Myelosuppression

United States, Bosnia and Herzegovina, Serbia, Bulgaria
University Children's Hospital Basel

Terminated

Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis

Streptococcal Infections

Switzerland
Sun Yat-sen University
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

PD-1 Blockade Combined With De-intensification Radical Chemoradiotherapy in Nasopharyngeal Carcinoma (DIAMOND)

Nasopharyngeal Carcinoma

China
University Hospital, Grenoble

Terminated

Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates

Kidney Transplantation | End-stage Renal Disease | Hla-incompatible Kidney Transplant Candidates

France
University of Hawaii

Withdrawn

Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1

Metastatic Pancreatic Cancer | ERCC1

United States
Vical

Completed

Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)

Influenza

United States
University of Maryland, Baltimore

Completed

Borderline Pancreas Study: FOLFIRINOX +SBRT (GCC 1324)

Resectable Pancreatic Cancer

United States
Hadassah Medical Organization

Unknown

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Breast Neoplasms

Israel
University of Chicago
National Cancer Institute (NCI)

Withdrawn

FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer

Ovarian Cancer

United States
CardioDynamics

Unknown

Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension (BETTER-HTN)

Hypertension

United States
GlaxoSmithKline

Completed

Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)

Atherosclerosis

United Kingdom
CardioDynamics

Unknown

PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing

Heart Failure, Congestive

United States
Eli Lilly and Company

Completed

Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer

Cancer

United States
Celyad Oncology SA
IQVIA Biotech

Completed

DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2 (DEPLETHINK)

AML | MDS

United States, Belgium
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy

Advanced Solid Tumor

United States
Memorial Sloan Kettering Cancer Center
Bristol-Myers Squibb

Completed

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Leukemia | Acute Lymphoblastic Leukemia

United States
Boston University
National Institute of Mental Health (NIMH); Massachusetts General Hospital; New... and other collaborators

Active, not recruiting

Supporting Sustained HIV Treatment Adherence After Initiation (SUSTAIN)

HIV Infections | Adherence, Medication

South Africa
Peking University People's Hospital
The University of Science and Technology of China

Unknown

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Yonsei University

Completed

A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin

Metastatic Advanced Gastric Cancer

Korea, Republic of
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
Shanghai Junshi Bioscience Co., Ltd.

Active, not recruiting

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma (JS001)

Metastatic Melanoma | Unresectable Melanoma

China
Hospital Clinic of Barcelona

Unknown

Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM) (EURDSS)

Atherosclerotic Cardiovascular Disease | Subclinical Disease and/or Syndrome

Spain
The Netherlands Cancer Institute
Roche Pharma AG; Borstkanker Onderzoek Groep

Active, not recruiting

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 (TRAIN-2)

Breast Cancer | HER2 Positive

Netherlands
Henan Cancer Hospital

Not yet recruiting

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial

Advanced Breast Cancer | Treatment | HR Low/HER2 Negative

3

Subscribe